Ye Lu
Guangzhou, 510280, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mesenchymal stromal cell-mediated mitochondrial transfer unveils new frontiers in disease therapy.
Journal: Stem cell research & therapy
Published: November 05, 2024
Laboratory investigation of METTL7A driving MSC osteogenic differentiation through YAP1 translation enhancement via eIF4F recruitment.
Journal: International endodontic journal
Published: September 06, 2024
Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis.
Journal: Frontiers in pharmacology
Published: September 18, 2023
Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation.
Journal: International immunopharmacology
Published: January 25, 2022
Anti-PD-L1 antibody alleviates pulmonary fibrosis by inducing autophagy via inhibition of the PI3K/Akt/mTOR pathway.
Journal: International immunopharmacology
Published: October 19, 2021
Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis.
Journal: Frontiers in pharmacology
Published: July 21, 2021
Tetrandrine Modulates Rheb-mTOR Signaling-Mediated Selective Autophagy and Protects Pulmonary Fibrosis.
Journal: Frontiers in pharmacology
Published: July 10, 2021
Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis.
Journal: Frontiers in pharmacology
Published: May 12, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026